These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 27507254)
1. Surgical spacer placement prior carbon ion radiotherapy (CIRT): an effective feasible strategy to improve the treatment for sacral chordoma. Lorenzo C; Andrea P; Barbara V; Denis P; Rosaria FM; Piero F; Viviana V; Alberto I; Mario C; Brugnatelli S; Tommaso D; Bugada D; Marcello M; Mario A; Francesca V; Roberto O; Paolo D World J Surg Oncol; 2016 Aug; 14(1):211. PubMed ID: 27507254 [TBL] [Abstract][Full Text] [Related]
2. Laparoscopic spacer placement for recurrent sacral chordoma before carbon ion radiotherapy: A case report. Nagai S; Nagayoshi K; Mizuuchi Y; Fujita H; Ohuchida K; Ohtsuka T; Imai R; Nakamura M Asian J Endosc Surg; 2020 Oct; 13(4):582-585. PubMed ID: 32097984 [TBL] [Abstract][Full Text] [Related]
3. Rectal dose-sparing effect with bioabsorbable spacer placement in carbon ion radiotherapy for sacral chordoma: dosimetric comparison of a simulation study. Shiba S; Okamoto M; Tashiro M; Ogawa H; Osone K; Yanagawa T; Kohama I; Okazaki S; Miyasaka Y; Osu N; Chikuda H; Saeki H; Ohno T J Radiat Res; 2021 May; 62(3):549-555. PubMed ID: 33783533 [TBL] [Abstract][Full Text] [Related]
4. Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma. Uhl M; Welzel T; Jensen A; Ellerbrock M; Haberer T; Jäkel O; Herfarth K; Debus J Strahlenther Onkol; 2015 Jul; 191(7):597-603. PubMed ID: 25737378 [TBL] [Abstract][Full Text] [Related]
5. Predictive role of Apparent Diffusion Coefficient (ADC) from Diffusion Weighted MRI in patients with sacral chordoma treated with carbon ion radiotherapy (CIRT) alone. Preda L; Casale S; Fanizza M; Fiore MR; Viselner G; Paganelli C; Buizza G; Fontana G; Vitolo V; Barcellini A; Baroni G; Fossati P; Valvo F Eur J Radiol; 2020 May; 126():108933. PubMed ID: 32171109 [TBL] [Abstract][Full Text] [Related]
6. Total spondylectomy following carbon ion radiotherapy to treat chordoma of the mobile spine. Matsumoto T; Imagama S; Ito Z; Imai R; Kamada T; Shimoyama Y; Matsuyama Y; Ishiguro N Bone Joint J; 2013 Oct; 95-B(10):1392-5. PubMed ID: 24078538 [TBL] [Abstract][Full Text] [Related]
7. Carbon Ion Radiation Therapy for Unresectable Sacral Chordoma: An Analysis of 188 Cases. Imai R; Kamada T; Araki N; Int J Radiat Oncol Biol Phys; 2016 May; 95(1):322-327. PubMed ID: 27084649 [TBL] [Abstract][Full Text] [Related]
8. Carbon ion radiotherapy for unresectable sacral chordomas. Imai R; Kamada T; Tsuji H; Yanagi T; Baba M; Miyamoto T; Kato S; Kandatsu S; Mizoe JE; Tsujii H; Tatezaki S; Clin Cancer Res; 2004 Sep; 10(17):5741-6. PubMed ID: 15355901 [TBL] [Abstract][Full Text] [Related]
9. Carbon ions therapy as single treatment in chordoma of the sacrum. Histologic and metabolic outcome studies. Evangelisti G; Fiore MR; Bandiera S; Barbanti Brodano G; Terzi S; Girolami M; Pipola V; Righi A; Nanni C; Fanti S; Ghermandi R; Molinelli S; Orecchia R; Boriani S; Gasbarrini A Eur Rev Med Pharmacol Sci; 2019 May; 23(9):4002-4009. PubMed ID: 31115029 [TBL] [Abstract][Full Text] [Related]
10. Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials. Imai R; Kamada T; Tsuji H; Sugawara S; Serizawa I; Tsujii H; Tatezaki S; Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1470-6. PubMed ID: 19939576 [TBL] [Abstract][Full Text] [Related]
11. MRI evaluation of sacral chordoma treated with carbon ion radiotherapy alone. Preda L; Stoppa D; Fiore MR; Fontana G; Camisa S; Sacchi R; Ghitti M; Viselner G; Fossati P; Valvo F; Vitolo V; Bonora M; Iannalfi A; Vischioni B; Vai A; Mastella E; Baroni G; Orecchia R Radiother Oncol; 2018 Aug; 128(2):203-208. PubMed ID: 29279241 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Oncologic Outcomes and Treatment-Related Toxicity of Carbon Ion Radiotherapy and En Bloc Resection for Sacral Chordoma. Yolcu YU; Zreik J; Wahood W; Bhatti AUR; Bydon M; Houdek MT; Rose PS; Mahajan A; Petersen IA; Haddock MG; Ahmed SK; Laack NN; Jethwa K; Jeans EB; Imai R; Yamada S; Foote RL JAMA Netw Open; 2022 Jan; 5(1):e2141927. PubMed ID: 34994795 [TBL] [Abstract][Full Text] [Related]
14. Carbon ion radiotherapy for sacral chordoma. Imai R; Kamada T; Sugahara S; Tsuji H; Tsujii H Br J Radiol; 2011 Dec; 84 Spec No 1(Spec Iss 1):S48-54. PubMed ID: 21427182 [TBL] [Abstract][Full Text] [Related]
15. Clinical outcome of sacral chordoma with carbon ion radiotherapy compared with surgery. Nishida Y; Kamada T; Imai R; Tsukushi S; Yamada Y; Sugiura H; Shido Y; Wasa J; Ishiguro N Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):110-6. PubMed ID: 20400242 [TBL] [Abstract][Full Text] [Related]
16. Changes in tumor volume of sacral chordoma after carbon ion radiotherapy. Serizawa I; Imai R; Kamada T; Tsuji H; Kishimoto R; Kandatsu S; Tsujii H; Tatezaki S J Comput Assist Tomogr; 2009; 33(5):795-8. PubMed ID: 19820514 [TBL] [Abstract][Full Text] [Related]
17. Sacral insufficiency fractures after high-dose carbon-ion based radiotherapy of sacral chordomas. Bostel T; Nicolay NH; Welzel T; Bruckner T; Mattke M; Akbaba S; Sprave T; Debus J; Uhl M Radiat Oncol; 2018 Aug; 13(1):154. PubMed ID: 30139357 [TBL] [Abstract][Full Text] [Related]
18. Carbon Ion Radiotherapy for sacral chordoma: a systematic review of the literature. Evangelisti G; Sartini F; Bandiera S; Barbanti Brodano G; Griffoni C; Girolami M; Pipola V; Gasbarrini A J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 3):353-361. Congress of the Italian Orthopaedic Research Society. PubMed ID: 33261300 [TBL] [Abstract][Full Text] [Related]
19. Carbon ion radiotherapy for sacral chordoma: A retrospective nationwide multicentre study in Japan. Demizu Y; Imai R; Kiyohara H; Matsunobu A; Okamoto M; Okimoto T; Tsuji H; Ohno T; Shioyama Y; Nemoto K; Nakano T; Kamada T; Radiother Oncol; 2021 Jan; 154():1-5. PubMed ID: 32941958 [TBL] [Abstract][Full Text] [Related]
20. A step towards international prospective trials in carbon ion radiotherapy: investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma. Vogin G; Wambersie A; Koto M; Ohno T; Uhl M; Fossati P; Balosso J; Radiat Oncol; 2019 Feb; 14(1):24. PubMed ID: 30709366 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]